Max Healthcare Board Approves FY26 Results, Recommends ₹2 Dividend, Approves Lucknow Hospital Project
Max Healthcare's Board approved FY26 audited financial results and recommended a ₹2 per share final dividend. The company also approved the construction of a new ~712-bed hospital in Lucknow and the shifting of its registered office to Haryana. The re-appointment of a Non-Executive Director was also approved.
The approval of financial results, dividend payout, and significant capital expenditure for a new hospital project have a material impact on the company's financials and strategic direction.
The approval of financial results, recommendation of dividend, and approval of new hospital construction and office shift are positive developments for the company.
Max Healthcare Institute Limited announced the outcome of its Board Meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company's statutory auditors, M/s. S.R. Batliboi & Co. LLP, have issued an unmodified audit report on these financial results.
Additionally, the Board recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26, subject to shareholder approval. This dividend is to be paid within 30 days from the conclusion of the upcoming Annual General Meeting (AGM).
The Board also approved the construction of Phase-I of the Max Super Specialty Hospital in Lucknow, which will accommodate approximately 712 beds. Furthermore, the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27 was approved. The Board also considered and approved the request for re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category, subject to stock exchange approvals.
In terms of corporate governance, the re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, was approved, pending member approval at the AGM. The Board also approved the shifting of the company's registered office from Maharashtra to Haryana, subject to member and regulatory approvals.
The Board meeting commenced at 12:07 PM IST and concluded at 3:44 PM IST.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.